Cargando…
Dual PI3K/ERK inhibition induces necroptotic cell death of Hodgkin Lymphoma cells through IER3 downregulation
PI3K/AKT and RAF/MEK/ERK pathways are constitutively activated in Hodgkin lymphoma (HL) patients, thus representing attractive therapeutic targets. Here we report that the PI3K/ERK dual inhibitor AEZS-136 induced significant cell proliferation inhibition in L-540, SUP-HD1, KM-H2 and L-428 HL cell li...
Autores principales: | Locatelli, Silvia Laura, Careddu, Giuseppa, Stirparo, Giuliano Giuseppe, Castagna, Luca, Santoro, Armando, Carlo-Stella, Carmelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073341/ https://www.ncbi.nlm.nih.gov/pubmed/27767172 http://dx.doi.org/10.1038/srep35745 |
Ejemplares similares
-
Current Role of Autologous and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
por: Castagna, Luca, et al.
Publicado: (2015) -
IER3 in pancreatic carcinogenesis
por: Molejon, Maria Inés, et al.
Publicado: (2015) -
Salvage Therapy for Hodgkin’s Lymphoma: A Review of Current Regimens and Outcomes
por: Castagna, Luca, et al.
Publicado: (2020) -
François Ier /
por: Castelot, André
Publicado: (1983) -
Estrogen receptor β ligation inhibits Hodgkin lymphoma growth by inducing autophagy
por: Pierdominici, Marina, et al.
Publicado: (2016)